Study to Evaluate Effects of Vorinostat and HXTC on Persistent HIV-1 Infection in HIV-Infected Subjects Started on Antiretroviral Therapy (ART)
Clinical trial NCT03212989 · COMPLETED
Trial details
- NCT number
- NCT03212989
- Sponsor
- University of North Carolina, Chapel Hill
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-06-27
- Primary completion
- 2022-06-07
- Enrollment
- 17
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.